An increasing number of studies have shown that air pollution containing particulate matter (PM) ≤ 2.5 µm (PM2.5) plays a significant role in the development of metabolic disorder and other chronic diseases. Inflammation and oxidative stress caused by metabolic syndrome are widely determined to be critical factors in the development of nonalcoholic fatty liver disease (NAFLD) pathogenesis. However, there is no direct evidence of this, and the underlying molecular mechanism is still not fully understood. In this study, we investigated the role of inflammation and oxidative stress caused by prolonged PM2.5 exposure in dyslipidemia-associated chronic hepatic injury, and further determined whether an increase in hepatic inflammation and oxidative stress promoted lipid accumulation in the liver, ultimately increasing the risk of NAFLD. Therefore, we studied changes in indicators of metabolic disorder and in symbolic indices of NAFLD. We confirmed increases in insulin resistance, glucose tolerance, peripheral inflammation and dysarteriotony in PM2.5-induced mice. Oxidative stress and inflammatory response in the liver caused by PM2.5 inhalation contributed to abnormal hepatic function, further promoting lipid accumulation in the liver. Moreover, we observed inhibition of oxidative stress and inflammatory response by pyrrolidine dithiocarbamate (PDTC) and N-acetyl-L-cysteine (NAC) in vitro, suggesting that oxidative stress and inflammatory in liver cells aggravated by PM2.5 contributed to hepatic injury by altering normal lipid metabolism. These results indicate a new goal for preventing and treating air pollution-induced diseases: suppression of oxidative stress and inflammatory response.
Introduction
Environmental air quality has become a concern of every country in the world. More importantly, air pollution has become a serious global threat [1] [2] [3] . Based on statistics derived from World Health Organization (WHO) surveys, outdoor air pollution is regarded as one of the primary factors that threaten health [4] [5] [6] . More than 9 out of 10 people whose health suffers from air pollution live in developing countries, and nearly 800,000 people have died from it in the past decade [7] [8] [9] . In China and India in particular, a serious challenge is presented by the side effects of rapid economic growth, such as air pollution and water pollution, which threaten human health [10] [11] [12] . maintaining organisms in steady-state balance. The emergence of metabolic syndrome as an important inducement of chronic organ injury has been widely confirmed [21, 22] . A previous study has indicated that mice exposed to PM2.5 air pollution suffered from dysarteriotony, insulin resistance (IR), systemic inflammatory response and neuroinflammation [13, 23] . Meanwhile, a growing body of research holds that systemic metabolic disorder is associated with the process of nonalcoholic fatty liver disease (NAFLD), ultimately resulting in liver dysfunction and injury [24] [25] [26] [27] . However, the underlying molecular mechanism of how NAFLD develops is still not fully understood. We based our preliminary experiment on the theory that long-term PM2.5 exposure can upregulate cholesterol and triglyceride of serum and liver tissues, leading to hepatic dyslipidemia; this suggests that air pollution may contribute to the risk of dyslipidemia-related NAFLD. Therefore, we attempted to understand the potential molecular mechanisms by which long-term air pollution contributes to the development of NAFLD.
Materials and methods

Study approval and ethics statement
All study protocols associating with animals were approved by the Institutional Animal Care and Use Committee in Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological and Chemical Engineering, Chongqing University of Education. The methods used in this research were in accordance with the Regulations of Experimental Animal Administration issued by the Ministry of Science and Technology of the People's Republic of China (http://www.most.gov.cn).
PM2.5 sampling collection and mice whole body exposure
The procedure of PM2.5 sampling preparation was in accordance with our previous descriptions, respectively [13, 14] . In brief, quartz filter (8 cm × 10 cm, 2500QAT-UP, Pallflex Products, Putnam, CT, USA) was used to consecutively and weekly harvest PM2.5 in Beijing and Xi'an, China (January-June 2016) at a flow rate of 166 L/min. The collected PM2.5 particle filters were stored in −80°C. The particle mass was subjected to anhydrous alcohol and 1% HNO3 solution, and then dissolved in double distilled water. Next, the mass was sonicated for 48 h and concentrated by vacuum freeze-drying. The freeze-dried extraction was resuspended in double distilled water and centrifuged at 5000 rpm to kick the water-soluble matter off. Finally, the water-insoluble portion was suspended in phosphate buffer (GIBCO Corporation, Gaithers-burg, MD, USA) for the following experiments. For the PM 2.5 sampling composition analysis, the PM 2.5 mass was detected using inductively coupled plasma-mass spectrometry (ICP-MS) platform (ELEMENT2; Thermo Finnigan, San Jose, CA, USA) (Supplementary Table 1 ). Male mice (C57BL/6; wild type) at the age of 6-8 weeks, weighing 18-25 g, were purchased from the Beijing Vital River Laboratory Animal Technology Co., Ltd (Beijing, China). All animal .5 exposure were detected using oral glucose tolerance test (OGTT); (B) Serum glucose levels in mice after MP or SP PM2.5 exposure were detected using insulin tolerance test (ITT); (C) Blood glucose changes in 6 months; (D-J) Physiological indicators of body weight, eWAT, iWAT, BAT weight, daily food intake, daily water intake and mean blood pressure (MBP) were investigated at 6th month after PM2.5 exposure. Data are shown as mean ± SEM. * P < 0.05 and ** P < 0.01 compared to chow (MP) or chow (SP) group. Δ P < 0.05 compared between MP and SP group.
(caption on next page) (Severe pollution based on China environmental pollution standards) (SP) or filtered air (FA) for 6 h/day, 5 times/week (Mon-Fri) in mobile whole body exposure system-HOPE-MED 8052 for 24 weeks (A constant flow of PM 2.5 airflow was introduced into a relatively closed cage, allowing the mice to move freely, drink, feed and naturally inhale PM2.5 particles at a constant concentration while breathing under a portable PM2.5 concentration monitor (TSI-8532 DUSTTRAK, USA); the instrument will check the concentration of PM 2.5 in the air of this cage every one hour to ensure that the requirements of the experimental design are met). All mice were divided into 4 groups: (1) mice with filtered air exposure (Chow-MP); (2) mice with filtered air exposure (Chow-SP); (3) mice with 24 weeks PM2.5 exposure (MP); and (4) mice with 24 weeks PM2.5 exposure (SP).
Cells culture
Collection of the kupffer cells (KCs) was carried out in accordance with the previous study and protocols with a few modifications [28, 29] . Briefly, 8 weeks healthy mice were selected and anaesthetized with diethyl ether. Subsequently the unbroken hepatic tissues were harvested without unnecessarily connective tissue and blood. The livers which was cut into pieces was infiltrated using pronase E and collagenase type I, Next, the mixture was cultured and shaken at 37°C for 30 min. After that, DNase I was added to this mixture to co-incubation for additional 20 min. Next, filtration with stainless steel mesh was done before washing the cells and dissolving erythrocyte with Trisammoniachloride. Gradient centrifugation was performed using 30-70% Percoll and maintained in culture flasks containing medium (Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum, 1 × 105 U/L streptomycin sulfate, pH 7.2 (GIBCO Corporation, Gaithersburg, MD, USA)) at a concentration of 1 × 10 5 /mL for 6 h, followed by removing of cells that are not attached to the 12-well plates with 37°C PBS buffer. For the isolation of hepatocytes, the collected liver tissues pieces were washed with D-Hanks' buffer for 2 times. Then, the pieces were incubated with collagenase IV and shaken at 25°C for 20 min. Filtration with stainless steel mesh was used to disperse liver tissues. All the filtered cells were maintained in centrifugal tube containing medium (DMEM medium supplemented with 10% fetal bovine serum, 1 × 10 5 U/L streptomycin sulfate (GIBCO Corporation, Gaithersburg, MD, USA)). These cells were next re-suspended and centrifuged with 1000 rpm for 5 min, 2 times. For another cells culture, the cell lines including normal rat hepatocyte line BRL-3A (ATCC® Number: CRL-1442™; American Tissue Culture Collection (USA)) and human liver cell line L02 (Cat NO.: CL-0111; Procell Life
Science & Technology Co.,Ltd., China) were cultured in corresponding medium according to relevant product specification. The different cells were cultured in 6-well or 12-well plates and then 80% confluent cultures were treated with or without 50 μg/mL or 100 μg/mL PM2.5 for 8 h at 37°C. Subsequently, the cells were collected and detected by qPCR test for the corresponding indicators.
Biochemical indicators analysis
After the last PM2.5 administrations, body weight of mice, daily water intake and mean blood pressure (Noninvasive blood pressure meter (Surgivet, USA)) were recorded. All mice were fasted for 12 h and blood samples were collected for biochemical analysis including routine analysis of blood, blood glucose, plasma insulin and lipid assay etc. Oral glucose tolerance testing (OGTT) and insulin tolerance testing (ITT) were performed to evaluate the insulin resistance. Mice were given an intraperitoneal injection of glucose (2 g/kg body weight), blood samples were collected from the tail vein immediately before and 0, 30, 60, 90 and 120 min after glucose administration, and blood glucose levels were measured using fast blood glucose test strips (Roche Group). For insulin tolerance testing, the mice were fasted for 4 h prior to an intraperitoneal injection of insulin (0.6 U/kg body weight). Blood samples were harvested from tail vein at 0, 30, 60, 90 and 120 min postinjection. Finally, in order to exclude disturbance from circadian rhythms caused hormone undulation, mice were painlessly killed at 9:00-10:00 a.m. with a dose of pentobarbital (5 mg/100 g body weight). Next, the epididymal white adipose tissue (eWAT), intraperitoneal white adipose tissue (iWAT) and brown adipose tissue (BAT) were measured. Then, the blood samples were investigated for hematological indicators analysis including white blood cells, red blood cells, hemoglobin, whole blood viscosity, whole blood reduction viscosity, plasma viscosity, packed cell volume, erythrocyte aggregation index, platelet counts, distribution width of red blood cells by volumestandard deviation, distribution width of red blood cells by volumecoefficient of variation, platelet volume distribution width, platelet aggregation rate-adenosine diphosphate; MPAR-Thr, platelet aggregation rate-threonine, prothrombin time, plasma fibrinogen, activated partial thromboplastin time, thrombin time, plasm D-dimer, antithrombin Ⅲ, plateletcrit, platelet large cell ratio, mean corpuscular hemoglobin, mean red blood cells hemoglobin concentration, mean corpuscular volume using animal blood analyzer (Drew, Hemavet, USA) (Exigo, Veterinary Hematology System, Sweden). Also, the inflammation, oxidative stress and lipid metabolism related indicators of serum or liver tissues including tumor necrosis factor-α, interleukin-1β, interleukin-6, interleukin-10, interferon-α, interferon-β, interferon-γ, interleukin-4, interleukin-17, interleukin-18, interleukin-2, interleukin-1, macrophage inflammatory protein-2, monocyte chemoattractant protein-1, macrophage inflammatory protein-3β, monocyte chemoattractant protein-3, procalcitonin, high mobility group box-1, macrophage-derived chemokine, macrophage inflammatory protein-1β, macrophage inflammatory protein-1α, granulocyte chemotactic protein-2, superoxide dismutase, glutathione peroxidase, total antioxidant capacity, nitric oxide, malondialdehyde, glutathione S-transferase, catalase, inducible nitric oxide synthase, reactive oxygen species, total cholesterol, total triacylglycerol, non-esterified fatty acid, urea nitrogen, lipid peroxidation, low density lipoprotein, high density lipoprotein, albumin, total protein, globulins, creatine kinase, total bilirubin, γ-glutamyl transpeptidase, acetylcholin esterase, Fig. 2 . Effects of long-term PM2.5 exposure on lipid accumulation and hepatic-function loss. Mice liver tissues were collected at 1st, 2nd, 4th and 6th month after MP (A) or SP (B) PM2.5 treatment. Liver tissues were subjected to H&E staining, oil red O staining and transmission electron microscope (TEM) analysis. Histopathological assessment of steatosis score (C), inflammation score (D), NAFLD activity score (E) and ballooning score (F) was displayed in these groups. Serum of ALT (G), AST (H) and AKP (I) levels were detected using corresponding commercial kits. Transmission electron microscope (TEM) showed the cell structure changes in MP and SP groups at 6th month after PM2.5 treatment. CN means cell nucleus;★ means lipid droplets in liver cells. Data are shown as mean ± SEM. * P < 0.05 and ** P < 0.01 compared to chow (MP) or chow (SP) group. Δ P < 0.05 and ΔΔ P < 0.05 compared between MP and SP group. Fig. 3 . Effects of long-term PM2.5 exposure on peripheral viscera pathology. Mice kidney, spleen and heart tissues were collected at 1st, 2nd, 4th and 6th month after MP (A) or SP (B) PM2.5 treatment. Tissues were subjected to H&E staining to evaluate the side-effect of prolonged PM2.5 exposure on peripheral organs pathology. Spleen weight (C) and liver weight (D) were examined in these groups. Data are shown as mean ± SEM. * P < 0.05 compared to chow (MP) or chow (SP) group.
butyrylcholinesterase were further detected using corresponding commercial kit, which were purchased from R&D system (China), Nanjing Jiancheng Bioengineering Institute (Nanjing, China), Beyotime Institute of Biotechnology (Nantong, China) or Solarbio life sciences (Beijing, China) according to the manufacturer's instructions. The levels of glutamic-oxalacetic transaminease, glutamic-pyruvic transaminase, alkline phosphatase in serum or liver tissues were tested using commercial kit of Nanjing Jiancheng Bioengineering Institute (Nanjing, China).
qPCR analysis
Trizol reagent (Cat: 15596-018; Thermo Fisher Scientific) was used to extract the total RNA samples. Different group tissues or cells were harvested and homogenized in Trizol reagent to yield a homogenate. Next, the final liquid supernatants were harvested by centrifugation at 12,000g for 15 min. Specifically, 1 μg of total RNA extraction was reverse transcribed using the M-MLV-RT system (Promega, Shanghai, China). The program was performed at 42°C for 1 h and terminated by deactivation of the enzyme at 70°C for 10 min qPCR were conducted using SYBR Green (Bio-Rad) in ABI PRISM 7900HT detection systems (Applied Biosystems). The primers used in this work were produced by Invitrogen Corporation (Supplementary Table 2 ). Pre-denatured products for amplification was performed at 94°C for 55 s; followed by 45 cycles at 95°C for 30 s, 57°C for 30 s and 73°C for 30 s; followed by 95°C for 10 s, 65°C for 45 s, and 40°C for 60 s. In brief, fold induction values were calculated according the 2-ΔΔ Ct expression, where ΔCt 
Histological analysis
The liver, kidney, heart, white adipose tissue and spleen samples in MP and SP groups were fixed with 4% paraformaldehyde, implanted in paraffin, and sectioned transversely. 3 µm sections were subjected to H &E or oil red O staining for the tissues injury determination derived from 3 pathologists by light microscopy. In addition, to determine liver injury regarding ER stress, liver tissues were collected and fixed in 1.25% glutaraldehyde/0.1 M PBS buffer, and post-implanted in 1% OsO 4 /0.1 M PBS buffer. 60 nm sections were cut on a microtome, placed on copper grids, stained with uranyl acetate and lead citrate, and evaluated with a Jeol JEM 1010 transmission electron microscope (TEM) (Jeol, Tokyo, Japan). For immumohistochemical staining, paraffin-embedded sections were deparaffinized before co-incubation with primary antibodies at 4°C overnight. Then, the secondary antibodies were incubated at 25°C for one hour. Sections were detected and filmed using Leica TCS SP5 microscopy with Openlab image software (Improvision, Lexington, MA, USA) or optical microscope (Leica DM1000 
Statistical analysis
Data were normally distributed and identified as the mean ± standard error of the mean (SEM). Statistical analyses were performed using GraphPad PRISM (version 7.0 for mac; Graph Pad Software) by one-way ANOVA with Dunnet's least significant difference post-hoc tests. A p-value less than 0.05 will be considered significant.
Results
The effects of prolonged PM2.5 exposure on metabolic disorder
As in previous studies, we first determined that in mice that had been subjected to whole-body PM2.5 exposure, such exposure might cause metabolic disorder and peripheral inflammatory reaction [13, 14] . We then estimated the significant effects of increasing concentrations of PM2.5 on development of abnormal physiological status. Therefore, the scope of our evaluation included glucose levels; body weight (BW); weights of epididymal white adipose tissue (eWAT), inguinal/subcutaneous WAT (iWAT) and brown adipose tissue (BAT); and mean blood pressure.
As shown in Figs. 1A and 1B, oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) analysis indicated that long-term PM2.5 exposure can induce IR, the presentation of which depends on PM2.5 dose. We further confirmed a significant increase in blood glucose levels from 0 to 24 weeks in these mice, compared with mice in a Chow group. Mice treated with SP PM2.5 exposure exhibited higher levels of glucose than did the MP group (Fig. 1C) . In addition, we measured BW; eWAT, iWAT and BAT weight; and daily food intake to investigate the side effects of prolonged PM2.5 exposure on the endocrine system and on metabolism. As shown in Figs. 1D-1H, we observed no significant differences in these indicators in either SP or MP mice exposed to PM2.5.
Consistent with previous reports, we next identified dysarteriotony in PM2.5 exposure-induced mice compared with Chow groups, suggesting that long-term PM2.5 exposure could promote abnormal blood pressure and an increase in daily water intake (Figs. 1I and 1J) . The above phenomena further indicated that long-term PM2.5 exposure significantly increased the risk of metabolic disorder.
Long-term PM2.5 exposure increases lipid accumulation and hepaticfunction loss
Several studies have shown that PM2.5 can cause peripheral-organ injury [14, [30] [31] [32] . Our preliminary experiment also confirmed that in animals exposed to PM2.5 over the long term, accelerated upregulation of tumor necrosis factor alpha (TNF-α) can cause hepatic inflammation and oxidative stress, collapsing the balance of lipid metabolism in the liver. In light of this, we investigated whether long-term PM2.5 exposure could increase hepatic dyslipidemia and loss of function. As shown in Figs. 2A and 2B , we subjected liver tissues collected from increasing times after MP and SP PM2.5 exposure to hematoxylin and eosin (H&E) and Oil Red O (ORO) staining and to transmission electron microscope (TEM) analysis. As expected, staining results revealed that steatosis (Fig. 2C), inflammation (Fig. 2D), NAFLD activity (Fig. 2E) and ballooning ( Fig. 2F) were all upregulated at both MP and SP levels of PM2.5 concentration with increasing exposure time, suggesting that high concentrations of inhaled PM2.5 aggravated NAFLD-related indicators of abnormal lipid metabolism and improper lipid accumulation in the liver. Meanwhile, due to imbalanced homeostasis induced by metabolic syndrome, we observed that lipid accumulation depended on the concentration of PM2.5 inhaled. In addition, as shown in previous These data are expressed as the mean ± SEM. TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; IL-6, interleukin-6; IL-10, interleukin-10; IFN-α, interferon-α; IFN-β, interferon-β; IFN-γ, interferon-γ; IL-4, interleukin-4; IL-17, interleukin-17; IL-18, interleukin-18; IL-2, interleukin-2; IL-1, interleukin-1; MIP-2, macrophage inflammatory protein-2; MCP-1, monocyte chemoattractant protein-1; MIP-3β, macrophage inflammatory protein-3β; MCP-3, monocyte chemoattractant protein-3; PCT, procalcitonin; HMGB1, high mobility group box-1; MDC, macrophage-derived chemokine; MIP-1β, macrophage inflammatory protein-1β; MIP-1α, macrophage inflammatory protein-1α; GCP-2, granulocyte chemotactic protein-2; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; T-AOC, total antioxidant capacity; NO, nitric oxide; MDA, malondialdehyde; GST, glutathione S-transferase; CAT, catalase; iNOS, inducible nitric oxide synthase; ROS, reactive oxygen species; TC, total cholesterol; TG, total triacylglycerol; NEFA, non-esterified fatty acid; BUN, urea nitrogen; LPO, lipid peroxidation; LDLs, low density lipoprotein; HDLs, high density lipoprotein; ALB, albumin; TP, total protein; GLO, globulins; CK, creatine kinase; TBIL, total bilirubin; γ-GT, γ-glutamyl transpeptidase; AchE, acetylcholin esterase; BchE, butyrylcholinesterase. * P < 0.05 versus chow (MP) or chow (SP). # P < 0.05 versus the 6th month after PM2.5 exposure (MP).
studies, various external-environmental stimuli can cause homeostatic imbalance and thus stress to the endoplasmic reticulum (ER). We then investigated whether long-term PM2.5 inhalation could affect ER structure. TEM images directly showed the broken ER in PM2.5-induced liver. At the same time, we also assessed levels of hepatic function--related indicators, including alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (AKP) levels in serum (Figs. 2G-2I) . A significant increase in serum ALT, AST and AKP expression were observed in both MP and SP stimulated mice; the presentation typically depending on PM2.5 dose, compared between the two groups. Of note, TEM analysis further confirmed the formation and aggregation of grease droplets in liver tissues (Fig. 2J) , suggesting that PM2.5 contributed to lipid accumulation and dysfunction of the liver associated with hepatic dyslipidemia to a concentration-dependent degree.
Hepatic inflammation and oxidative stress induced by PM2.5 exposure contribute to liver dyslipidemia
Oxidative stress triggered by PM2.5 inhalation promotes organic inflammatory infiltration. More and more studies also suggest that PM2.5 administrations can upregulate inflammatory cytokines and chemokines released in serum and tissue, which further induces chronic organic injury [14, 23, 31] . In light of this, we first compared the effects of whole-body PM2.5 inhalation on mouse hearts, kidneys and spleens in the 1st, 2nd, 4th and 6th months after exposure. As indicated in Figs. 3A-3D , inflammatory infiltration in the kidney, heart and spleen and weight loss of the kidney and spleen were significantly observed in both MP-and SP-treated mice, suggesting that prolonged PM2.5 contamination was involved in chronic organic injury in a manner typically dependent on concentration and dose.
Based on these results, we next investigated the possible relationship between PM2.5-stimulated liver dyslipidemia and chronic hepatic inflammation and oxidative stress. As shown in Fig. 4A , we detected the expression of ALT, AST and AKT in liver tissues. These hepatic indicators were significantly higher in the PM2.5-induced mice than in the Chow mice. Of note, ALT, AST and AKT levels in SP mice were higher than in MP mice, suggesting that chronic liver injury could be induced by air pollution depending on the concentration of PM2.5.
Other studies have found inflammatory response and oxidative stress to be key triggers of metabolic-disorder development [32] . In light of this, we next evaluated changes in indicators of inflammation and oxidative stress and the effects on hepatic lipid metabolism. As shown in Figs. 4B and 4C, we detected inflammation-related indices, including TNF-α, interleukin-1β and -6 (IL-1β and IL-6), TNF receptors 1 and 2 (TNFR1 and TNFR2), TNF-α-converting enzyme (TACE), inactive rhomboid protein 2 (iRhom2), receptor-interacting proteins 3 and 1 (RIP3 and RIP1), inhibitor of NF-κB kinase subunit alpha (IKK-α), Tat-associated kinase (TAK), IKK subunit beta (IKK-β), nuclear factor of κ-light polypeptide gene enhancer in B-cells inhibitor-α (IκBα), mixedlineage kinase domain-like (MLKL) protein, dynamin-related protein 1 (DRP1) and nucleotide-binding domain-like receptor protein 3 (NLRP3). As expected, these indicators were significantly upregulated in PM2.5-exposed mice compared with Chow mice. As with ALT, we detected significantly higher messenger RNA (mRNA) expression of AST and AKT in the livers of SP mice compared with MP mice, suggesting long-term PM2.5 exposure may affect liver function and aggravate chronic hepatic inflammatory response. In particular, levels of TNF-α, IL-1β, IL-18 and IL-6 proteins were significantly increased in liver tissues. Detection of inflammation-associated indicators changes indicated that mice exposed long-term to PM2.5 may indeed suffer systemic chronic hepatic inflammation related to metabolic syndrome. We also determined the underlying effects of PM2.5 contamination on oxidative stress in liver tissues. At this juncture, we introduced new indicators to our study, including heme oxygenase 1 (HO-1), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), kelch-like epichlorohydrinassociated protein 1 (Keap-1), inducible nitric oxide synthase (iNOS), superoxide dismutase 1 and 2 (SOD1 and SOD2), PEAK, activating transcription factor 6 (ATF6), glutamate-cysteine ligase, modifier and catalytic subunits (GCLM and GCLC), NAD(P)H dehydrogenase [quinone] 1 (NQO1), forkhead box protein O1 (FOXO1) and histone deacetylase 3 (HDAC3). Abnormal upregulation of oxidative stress caused by PM2.5 exposure was responsible for the metabolic-disorder and systemic inflammatory response. Typical pro-oxidants and anti-oxidants such as HO-1, SOD1, SOD2, xanthine oxidase (XO), H 2 O 2 and O 2 -were detected in both Chow and contaminated mice (Figs. 4D and 4E) . Enhancement in Nrf2 signaling pathway and its downstream anti-oxidants played a role in PM2.5-induced hepatic oxidative stress. We also observed significant upregulation of XO, xanthine dehydrogenase (XDH), H 2 O 2 and O 2 -, indicating oxidative stress caused by PM2.5 exposure may be an important contributor to chronic liver injury. Oxidative stress and systemic inflammatory reaction have been identified as the main causes of chronic organic injury induced by PM2.5. The liver is the main organ and a critical site of lipid metabolism. Liver dysfunction induced by oxidative stress and inflammatory response could disturb lipid metabolism, possibly promoting the process of hepatic dyslipidemia and increasing risk of NAFLD. Therefore, we next assessed changes to levels of hepatic lipid-metabolism indicators in mRNA. Genes regulating such processes as cholesterol synthesis and efflux, as well as fatty-acid uptake, synthesis and β-oxidation (Fig. 4F) , were detected. As expected, we observed a significant increase in cholesterol synthesis (3- . Also, upregulation of total cholesterol (TC), triglyceride (TG), non-essential fatty-acid (NEFA) and very-low-density-lipoprotein (VLDL) levels (Fig. 4G ) in liver tissue further suggested that prolonged PM2.5 exposure may lead to abnormal hepatic-lipid metabolism.
We performed immunohistochemical (IHC) analysis for expression of SCD1, SREBP-1 and PPAR-α in the liver (Fig. 4H) . Positive SCD1 and SREBP-1 expression was significantly observed in both the MP and SP Fig. 6 . PM2.5 exposure increased inflammatory response and oxidative stress in vitro. (A-F) Kupffer cells, BRL-3A cells, hepatocytes and L02 cells were treated with 50 μg/mL or 100 μg/mL PM2.5 for 8 h. Real-time fluorescence quantitative PCR detected inflammation and oxidative stress-related genes expression changes. * P < 0.05 compared to control group. Δ P < 0.05 compared to 50 μg/mL PM2.5.
groups. H&E staining results for WAT (Fig. 4I ) further suggested that dose-dependent PM2.5 can induce fat lesions. Notably, as shown in Figs. 5A and 5B, an immunofluorescent assay for levels of p-IκBα, SCD1, Nrf2 and PPAR-α further confirmed that increases in inflammation and oxidative stress could lead to changes in indicators associated with the metabolism of lipids in the liver, suggesting that PM2.5-induced oxidative stress and liver inflammatory response contributed to the process of dyslipidemia in liver.
To better illustrate the side effects of PM2.5 on metabolism and the endocrine system, we summarized the analysis data on indicators of inflammation, oxidative stress and lipid metabolism in the serum of PM2.5-induced mice. As shown in Table 1 , a total of 51 indices in different mouse groups exhibited changes and differences to various significant extents. This analysis provided more evidence that long term PM2.5 exposure could increase the risk of NAFLD by triggering upregulation of dyslipidemia. Meanwhile, serious liver function loss can affect coagulation. We further analyzed hematological indicators in PM2.5-induced mice ( Table 2 ) and found that a total of 25 indicator changes in PM2.5 different groups displayed significant differences, compared with the corresponding Chow mice. These changes in blood parameters suggested that long-term PM2.5 exposure may affect coagulation related to liver function.
Suppression of inflammatory response and oxidative stress restrains abnormal lipids metabolism in vitro
To investigate how PM2.5-induced inflammatory response and oxidative stress may be related to abnormal lipid metabolism, via in vitro experiments we extensively studied the changes in gene expression levels. During this phase we introduced Kupffer, BRL-3A, hepatocyte and L02 cells. All cell lines were treated with medium containing 50 or 100 μg/mL PM2.5 for 8 h. As shown in Figs. 6A-6F, we noted a series of significant changes in inflammatory-and oxidative-stress-related indices, including expression of TNF-α, IL-6, IL-1β, iNOS, cyclooxygenase-2 (COX-2), GCLM, IκBα, IKKβ, IKKα, Nrf2, Keap-1, HO-1, chemokine (C-X3-C motif) ligand 1 (CX3CL1), monocyte chemoattractant protein 1 (MCP-1), chemokine (C-C motif) ligand 3 (CCL3), ATF6, ATF4 and FOXO1. These changes showed that in vitro, different lines of cells treated with PM2.5 displayed greater inflammatory response and oxidative-stress levels depending on PM2.5 dose.
As shown in Figs. 7A-7F, we examined lipid-metabolism-related indicators, including SREBP-1c and SREBP-2, PPARα, PPAR-γ, SCD1, FAS, liver X receptor alpha (LXRα), malate dehydrogenase 1 (MDH1), adipose differentiation-related protein (ADFP), ACCα, CPT1A, glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), glucose-6-phosphatase, catalytic subunit (G6PC), MCAD, LCAD, apolipoprotein B (ApoB), Mel and phosphoenolpyruvate carboxykinase 1 (PCK1) to investigate the effects of dose-dependent concentrations of PM2.5 on mRNA levels in liver cell lines. As expected, cells treated with PM2.5 significantly increased synthesis and uptake of fatty-acid-related gene expression. The reduction in fatty-acid oxidation mRNA levels also suggested that PM2.5 could affect lipid metabolism in liver cells. These in vitro experiments showed that abnormal lipid metabolism in the liver caused by PM2.5 exposure is associated with PM2.5-induced oxidative stress and inflammation. To prove this more directly, we blocked the NF-κB and oxidativestress-signaling pathway using NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) and N-acetyl-L-cysteine (NAC) to determine whether suppression of inflammation and oxidative-stress levels could restrain abnormal lipid-metabolism-related gene expression. All cells were pretreated with 50 μM PDTC and 5 mM NAC for 60 min, followed by 50 or 100 μg/mL PM2.5 for an additional 8 h. Inhibition of NF-κB signaling (Figs. 8A and 8B) and oxidative stress (Figs. 9A and 9B) directly reduced inflammation and oxidative-stress-associated gene expression in liver tissues. We observed a significant reduction in genes associated with lipid accumulation in different cell lines co-treated with PM2.5 mass and/or PDTC or NAC (Figs. 8C and 9C ), suggesting that oxidative stress and inflammation caused by PM2.5 administration is a major promoter of dyslipidemia in liver tissue.
Discussion
Extensive epidemiological studies have demonstrated that airborne fine-particulate matter is a serious threat to human health worldwide, and that PM2.5 exposure in particular increases morbidity and mortality of cardiovascular, cerebrovascular and pulmonary diseases and of endocrine disorder [1] [2] [3] [16] [17] [18] [19] [20] . As the medical knowledge has evolved, the role played by the side effects of rapid economic development in metabolic disorder, especially PM2.5 mass-as evidenced by PM2.5-induced IR, neuroinflammation, airway inflammation and chronic renal injury-have received greater attention. However, little research exists on the potential pathogenic molecular mechanism by which long-term PM2.5 exposure promotes abnormal lipid-metabolism-associated NAFLD and thus causes liver disease, and so this mechanism is still not fully understood. We therefore investigated whether a PM2.5-induced increase in the risk of NAFLD is associated with PM2.5-induced oxidative stress and inflammation in the liver.
We used mice exposed to different concentrations of PM2.5 mass (MP and SP) for 6 continuous months as a model, then introduced indicators of metabolic disorder to the study. We found that 6-month whole-body PM2.5 exposure can result in metabolic syndrome; this was demonstrated by IR, glucose tolerance, reduction in weight of immunological organs and abnormal blood pressure, as evidenced by OGTT and ITT results and by blood pressure readings. Meanwhile, our analysis of indicators of inflammation, oxidative stress and lipid metabolism in PM2.5-induced mouse serum or liver tissues also showed a significant increase in systemic inflammation and oxidative stress during PM2.5 exposure, consistent with earlier studies. It suggested that * P < 0.05 compared to 100 μg/mL PM2.5. Fig. 10 . The conceivable working model of the role of oxidative stress in long term PM 2.5 exposure-induced increased risk of nonalcoholic fatty liver disease. Prolonged PM2.5 inhalations could lead to metabolic disorder by up regulation of inflammatory responses and oxidative stress and further mediate organ immune response. Particular matter could directly enter circulation, further affect process of normal hepatic function by enhancement of inflammatory cytokines and chemokines produce and increase of reactive oxygen species, ultimately resulting in the occurrence of abnormal lipids metabolism, elevating risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.
On the other hand, overexpression of oxidative stress and inflammatory responses significantly suppressed antioxidants release and anti-oxidative stress activity, further aggravated hepatic injury and lipid accumulation, expressively helped to establishment of oxidative stress-driven nonalcoholic fatty liver disease.
prolonged PM2.5 exposure could promote systemic metabolic disorder in a typically dose-dependent manner in mice. In addition, histological examination of liver tissues from MP and SP mice indicated significant increases in inflammatory infiltration and in scores for steatosis, NAFLD activity and ballooning, compared with the corresponding Chow mice. This indicated that the risk of NAFLD activity was heightened in mice subjected to long-term PM2.5 inhalation. ORO staining and TEM analysis of liver tissue sections further confirmed the increase in hepatic lipid accumulation and ER destruction in both MP and SP mice.
Previous studies have illustrated that abnormal upregulation of oxidative stress and inflammation caused by stimulants can aggravate hepatic dyslipidemia and lipid accumulation, ultimately promoting development of NAFLD [24, 33, 34] . In light of this, we assessed indicators of inflammation, oxidative stress and lipid metabolism to determine their potential relationship in mice whose PM2.5 exposure increased their risk of NAFLD. We confirmed increases in hepatic ALT, AST and AKP levels after PM2.5 treatment, suggesting that prolonged PM2.5 contamination may lead to dysfunction of the liver.
In addition, extensive routine blood tests also confirmed abnormal liver function. Overexpression of pro-inflammatory and oxidative-stress genes resulted in chronic liver injury, evidenced by increases in inflammatory cytokines (TNF-α, IL-1β, IL-18 and IL-6) and pro-oxidants (XO, XDH, H 2 O 2 and O 2 -). Further analysis of transcriptional levels of lipid metabolism-including cholesterol synthesis and efflux, as well as fatty-acid uptake, synthesis and β-oxidation-found that the expression of genes related to lipid accumulation was significantly upregulated, cooperated with increases in liver TG, TC, NEFA and VLDL levels. This indicated that PM2.5-induced hepatic inflammation and oxidative stress contributed to the process of NAFLD by promoting abnormal lipid metabolism and accumulation in the liver.
Furthermore, immunohistochemistry analysis of SCD1, SREBP1 and PPAR-α in stained liver tissues further confirmed the relationship between prolonged PM2.5 exposure and NAFLD in mice. To better understand the molecular mechanism by which PM2.5-induced inflammation and oxidative stress contribute to NAFLD, at this juncture we introduced PDTC and NAC, which inhibit NF-κB and oxidative stress, to our in vitro experiments. Kupffer, BRL-3A, hepatocyte and L02 cells were co-treated with or without PM2.5 and/or PDTC or NAC. As expected, as expression of genes associated with inflammation and oxidative stress decreased, so did that of genes associated with abnormal lipid metabolism. Gene expression associated with cholesterol synthesis and with fatty-acid uptake and synthesis was significantly suppressed. These results confirm that prolonged PM2.5 exposure contributed to hepatic oxidative stress and inflammatory response, which further aggravated the process and development of abnormal lipid metabolism.
Altogether, as shown in Fig. 10 , in our current study we demonstrated that oxidative stress and inflammation were the mechanisms by which PM2.5 caused chronic liver injury and increased the risk of NAFLD. Upregulation of these mechanisms induced by PM2.5-caused metabolic disorder resulted in further hepatic injury and loss of liver function due to lipid accumulation. These results may provide new insight into our knowledge of the potential molecular mechanism by which prolonged PM2.5 exposure increases the risk of NAFLD associated with metabolic disorder.
